BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22661188)

  • 1. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
    Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
    Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
    Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
    Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
    Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
    Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
    Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
    Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
    Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
    Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells.
    Tanaka Y; Kume S; Araki H; Nakazawa J; Chin-Kanasaki M; Araki S; Nakagawa F; Koya D; Haneda M; Maegawa H; Uzu T
    Free Radic Biol Med; 2015 Dec; 89():831-41. PubMed ID: 26482866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide.
    Swaminathan S; Birudukota S; Thakur MK; Parveen R; Kandan S; Juluri S; Shaik S; Anand NN; Burri RR; Kristam R; Hallur MS; Rajagopal S; Schreuder H; Langer T; Rudolph C; Ruf S; Dhakshinamoorthy S; Gosu R; Kannt A
    Biochem Biophys Res Commun; 2017 Sep; 491(2):416-422. PubMed ID: 28720493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse liver nicotinamide N-methyltransferase pharmacogenetics: biochemical properties and variation in activity among inbred strains.
    Scheller T; Orgacka H; Szumlanski CL; Weinshilboum RM
    Pharmacogenetics; 1996 Feb; 6(1):43-53. PubMed ID: 8845860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples: evidence for substrate inhibition kinetics.
    Patel M; Vasaya MM; Asker D; Parsons RB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():87-95. PubMed ID: 23435346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms.
    Yan L; Otterness DM; Craddock TL; Weinshilboum RM
    Biochem Pharmacol; 1997 Nov; 54(10):1139-49. PubMed ID: 9464457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells.
    Yamada K; Miyazaki T; Hara N; Tsuchiya M
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):83-6. PubMed ID: 20495288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic effects of nicotinamide methylation on mouse brain striatum neuronal cells and its relation to manganese.
    Mori Y; Sugawara A; Tsuji M; Kakamu T; Tsuboi S; Kanda H; Hayakawa T; Fukushima T
    Environ Health Prev Med; 2012 Sep; 17(5):371-6. PubMed ID: 22249857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD
    Komatsu M; Kanda T; Urai H; Kurokochi A; Kitahama R; Shigaki S; Ono T; Yukioka H; Hasegawa K; Tokuyama H; Kawabe H; Wakino S; Itoh H
    Sci Rep; 2018 Jun; 8(1):8637. PubMed ID: 29872122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.
    Neelakantan H; Vance V; Wetzel MD; Wang HL; McHardy SF; Finnerty CC; Hommel JD; Watowich SJ
    Biochem Pharmacol; 2018 Jan; 147():141-152. PubMed ID: 29155147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice.
    Przyborowski K; Wojewoda M; Sitek B; Zakrzewska A; Kij A; Wandzel K; Zoladz JA; Chlopicki S
    PLoS One; 2015; 10(6):e0130908. PubMed ID: 26115505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway.
    Xie X; Liu H; Wang Y; Zhou Y; Yu H; Li G; Ruan Z; Li F; Wang X; Zhang J
    Oncotarget; 2016 Jul; 7(29):45837-45848. PubMed ID: 27323852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine.
    Riederer M; Erwa W; Zimmermann R; Frank S; Zechner R
    Atherosclerosis; 2009 Jun; 204(2):412-7. PubMed ID: 18996527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.
    Ruf S; Hallur MS; Anchan NK; Swamy IN; Murugesan KR; Sarkar S; Narasimhulu LK; Putta VPRK; Shaik S; Chandrasekar DV; Mane VS; Kadnur SV; Suresh J; Bhamidipati RK; Singh M; Burri RR; Kristam R; Schreuder H; Czech J; Rudolph C; Marker A; Langer T; Mullangi R; Yura T; Gosu R; Kannt A; Dhakshinamoorthy S; Rajagopal S
    Bioorg Med Chem Lett; 2018 Mar; 28(5):922-925. PubMed ID: 29433927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Ström K; Morales-Alamo D; Ottosson F; Edlund A; Hjort L; Jörgensen SW; Almgren P; Zhou Y; Martin-Rincon M; Ekman C; Pérez-López A; Ekström O; Perez-Suarez I; Mattiasson M; de Pablos-Velasco P; Oskolkov N; Ahlqvist E; Wierup N; Eliasson L; Vaag A; Groop L; Stenkula KG; Fernandez C; Calbet JAL; Holmberg HC; Hansson O
    Sci Rep; 2018 Feb; 8(1):3016. PubMed ID: 29445118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.